Valsartan

Consult with Our Legal Team
You will be contacted by a member of the Investor Claims team within 24 hours.

1 of 13
For The Advocacy You Deserve Contact Us Today!
We’ll respond and let you know the best way to proceed with your case.

Valsartan, Losartan, and Irbesartan: Contamination and Legal Action

The Carcinogenic Contamination

Meyer Wilson is pursuing claims related to certain batches of Valsartan, Losartan, and Irbesartan, which were contaminated with N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), known human carcinogens, but were still sold to US consumers for years.

These contaminated drugs were widely prescribed to treat high blood pressure and other cardiovascular conditions, putting countless patients at risk of developing cancer.

NDMA and NDEA: Potent Carcinogens

NDMA and NDEA are highly potent carcinogenic compounds identified as "cohorts of concern" by regulatory agencies due to their ability to cause genetic mutations. These N-Nitroso compounds serve no legitimate function aside from inducing cancer in laboratory animals.

Exposure to these substances, even at low levels, can significantly increase the risk of various types of cancer.

Manufacturers' Negligence

The contamination allegedly resulted from systemic quality assurance failings at manufacturing facilities in China and India operated by Zhejiang Huahai Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals, Hetero Labs, Torrent Pharmaceuticals, Aurobindo Pharmaceuticals and others.

These companies failed to implement proper safety protocols and quality control measures, leading to the widespread distribution of contaminated drugs.

FDA Recalls and Import Alerts

In 2018, upon discovering these companies had been manufacturing and selling generic products containing carcinogens for years, the FDA initiated an unprecedented recall for all unexpired batches and placed many facilities on import alert, preventing their products from entering the United States.

However, by that time, countless patients had already been exposed to the contaminated drugs, putting their health at risk.

Meyer Wilson's Legal Efforts

Layne Hilton, Lead Counsel in Meyer Wilson's Mass Torts practice, was appointed to the Plaintiffs' Steering Committee for the In re Valsartan, Losartan and Irbesartan Products Liability Litigation.

She has been integrally involved in various aspects of the case, including taking depositions of key corporate witnesses,, briefing, and arguing discovery issues. Meyer Wilson is committed to holding the responsible parties accountable and securing justice for those affected by the contaminated drugs.

Potential Claims

The plaintiffs seek recovery for economic losses, medical monitoring costs, or personal injuries suffered from developing certain cancers due to ingesting these defective products.

Individuals who have been diagnosed with cancer after taking contaminated Valsartan, Losartan, or Irbesartan may be eligible to file a claim against the manufacturers if they suffer from the following cancers:

  • Bladder Cancer
  • Blood Cancer
  • Breast Cancer
  • Colorectal/Intestinal Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Uterine Cancer

Contact Meyer Wilson

If you developed cancer after consuming contaminated Valsartan, Losartan, or Irbesartan, contact Meyer Wilson at 866-938-2021 to discuss a potential claim. Their experienced legal team is dedicated to fighting for the rights of those affected by this devastating contamination scandal.

FAQ

  1. Q: What specific cancer types are associated with contaminated Valsartan, Losartan, and Irbesartan use?
    1. Cancers potentially linked to these contaminated drugs include bladder, blood, breast, colorectal, esophageal, gastric, kidney, liver, lung, pancreatic, prostate, and uterine cancers. Patients who developed these cancers after taking the medications may be eligible to file a claim.
  2. Q: How did NDMA and NDEA contaminants get into blood pressure medications like Valsartan?
    1. The contamination resulted from quality control failures at manufacturing facilities in China and India. Companies failed to implement proper safety protocols, leading to the introduction of these carcinogenic compounds into the medications.
  3. Q: What immediate actions did the FDA take when Valsartan contamination was discovered?
    1. In 2018, the FDA recalled all unexpired batches of contaminated drugs and placed many manufacturing facilities on import alert. However, many patients had already been exposed to the contaminated medications by this time.
  4. Q: Is there a time limit for filing a lawsuit if I develop cancer after taking contaminated Valsartan?
    1. Time limits vary depending on your situation and state laws. Consult with an experienced attorney as soon as possible after a cancer diagnosis if you previously took contaminated Valsartan, Losartan, or Irbesartan.
  5. Q: What compensation can I seek in a lawsuit for cancer caused by contaminated blood pressure medication?
    1. Potential compensation may include recovery for economic losses, medical monitoring costs, and personal injuries related to cancer development. This can cover medical expenses, lost wages, and pain and suffering.
Meyer Wilson
Meyer Wilson
Quick Links
The information contained in this Website is provided for informational purposes only, and should not be construed as legal advice on any subject matter. No recipients of content from this site, clients or otherwise, should act or refrain from acting on the basis of any content included in the site without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in the recipient's state. Read More
The information contained in this Website is provided for informational purposes only, and should not be construed as legal advice on any subject matter. Read More
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram